Treatment of Seizures Associated with Lennox-Gastaut and Dravet Syndromes: A Focus on Cannabidiol Oral Solution.

Répertoire NCBI simple obtenir commencé NCBI formation NCBI aide NCBI manuel manuel & tutoriels soumettre des ressources de données chimiques & BioassaysData & SoftwareDNA & RNADomains & StructuresGenes & ExpressionGenetics & MedicineGenomes & MapsHomologyLiteratureProteinsSequence AnalysisTaxonomyVariation populaire PubMed Bookshelf PubMed Central BLAST nucléotide génome SNP gène protéine PubChem vedette génétiques test Read more…

Partage le savoir

Cannabidiol as adjunctive treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome.

gmail.com.2Department of Neurology, Christian Doppler Klinik, Paracelsus Medical University, Salzburg, Austria; Center for Cognitive Neuroscience, Salzburg, Austria; Public Health, Health Services Research and HTA, University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria.3Department of Science of Health, University of Catanzaro, Catanzaro, Italy.4Pediatric Neurology and Muscular Diseases Unit, Read more…

Partage le savoir

Cannabidiol chez des patients atteints du syndrome de Lennox-Gastaut : analyse intérimaire d’une étude de prolongation ouverte.

2019 les auteurs. Epilepsia publié par Wiley périodiques, Inc. au nom de la Ligue internationale contre l’épilepsie. MOTS CLÉS : anticonvulsivant ; cannabinoïdes ; épilepsie de l’enfance-apparition ; crises de goutte PMID : 30740695 DOI : 10.1111/epi.14670 ShareGrant supportGrant supportGW Research Ltd., Cambridge, UK / contenu supplémentaire– View the Original article Partage le savoir

Partage le savoir

Epidiolex (Cannabidiol): A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes.

2 years old with DS and LGS and is well tolerated. KEYWORDS: CBD; Dravet; Epidiolex; GWP42003-P; Lennox-Gastaut; antiseizure medications; cannabidiol; epilepsy; seizure; treatment-resistant epilepsy PMID: 30616356 DOI: 10.1177/1060028018822124 ShareLinkOut – more resourcesFull Text SourcesAtypon Supplemental Content Full text links View the Original article Partage le savoir

Partage le savoir

Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta-Analysis.

 50% reduction in baseline drop and non-drop seizure frequency, and the incidence of treatment withdrawal and adverse events (AEs). Risk ratios (RRs) with 95% confidence intervals (CIs) were estimated through the inverse variance method. RESULTS: Two trials were included involving 396 participants. Patients presenting  View the Original article Partage le Read more…

Partage le savoir
error: Content is protected !!